Iram Fatima, Ph.D.

About Iram Fatima, Ph.D.

Iram Fatima, Ph.D., With an exceptional h-index of 15 and a recent h-index of 12 (since 2020), a distinguished researcher at University of Nebraska Medical Center, specializes in the field of Molecular Biology, Cancer Biology, Endometrial Cancer, Breast Cancer, Colon Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20

Inflammation and Cancer: Role of Tight Junctions

Discovery, synthesis and biological evaluation of a series of N-(phenylcarbamothioyl)-2-napthamides as inhibitors of Claudin-1

Identification and characterization of a first-generation inhibitor of claudin-1 to inhibit colon cancer progression and metastasis

Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer

Targeting Wnt signaling in endometrial cancer

Pancreatic cancer and therapy: role and regulation of cancer stem cells

MASTL regulates EGFR signaling to impact pancreatic cancer progression

Iram Fatima, Ph.D. Information

University

Position

Instructor Omaha NE USA

Citations(all)

633

Citations(since 2020)

421

Cited By

354

hIndex(all)

15

hIndex(since 2020)

12

i10Index(all)

20

i10Index(since 2020)

14

Email

University Profile Page

Google Scholar

Iram Fatima, Ph.D. Skills & Research Interests

Molecular Biology

Cancer Biology

Endometrial Cancer

Breast Cancer

Colon Cancer

Top articles of Iram Fatima, Ph.D.

Title

Journal

Author(s)

Publication Date

Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20

British journal of cancer

Iram Fatima

Rizwan Ahmad

Susmita Barman

Saiprasad Gowrikumar

Kristina Pravoverov

...

2024/1/26

Inflammation and Cancer: Role of Tight Junctions

Kristina Pravoverov

Susmita Barman

Saiprasad Gowrikumar

Iram Fatima

Santosh Kumar Yadav

...

2023/10/13

Discovery, synthesis and biological evaluation of a series of N-(phenylcarbamothioyl)-2-napthamides as inhibitors of Claudin-1

Journal of natural products

David A Brumley

Sarath P Gunasekera

Thomas Sauvage

Larissa AH Dos Santos

Qi-Yin Chen

...

2022/2/15

Identification and characterization of a first-generation inhibitor of claudin-1 to inhibit colon cancer progression and metastasis

Cancer Research

Iram Fatima

Jaya Prakash Uppada

Yashpal S Chhonker

Saiprasad Gowrikumar

Susmita Barman

...

2023/4/4

Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer

Cancer Letters

Mark Primeaux

Xiangdong Liu

Saiprasad Gowrikumar

Iram Fatima

Kurt W Fisher

...

2023/11/28

Targeting Wnt signaling in endometrial cancer

Iram Fatima

Susmita Barman

Rajani Rai

Kristina W Thiel

Vishal Chandra

2021/5/13

Pancreatic cancer and therapy: role and regulation of cancer stem cells

Susmita Barman

Iram Fatima

Amar B Singh

Punita Dhawan

2021/4/30

MASTL regulates EGFR signaling to impact pancreatic cancer progression

Oncogene

Iram Fatima

Susmita Barman

JayaPrakash Uppada

Shailender Chauhan

Sanchita Rauth

...

2021/9/23

Albendazole enhances apoptosis through targeting RNF20/Eg5 interaction in colon cancer cells

Cancer Research

Iram Fatima

Rizwan Ahmad

Saiprasad Gowrikumar

Susmita Barman

Rafay Abu

...

2021/7/1

MASTL: A novel therapeutic target for Cancer Malignancy

Cancer Medicine

Iram Fatima

Amar B Singh

Punita Dhawan

2020/7

See List of Professors in Iram Fatima, Ph.D. University(University of Nebraska Medical Center)

Co-Authors

academic-engine